Literature DB >> 19966566

Perspectives on the etiology of chronic rhinosinusitis.

Bruce K Tan1, Robert P Schleimer, Robert C Kern.   

Abstract

PURPOSE OF REVIEW: This article reviews recent insights surrounding the etiology and pathogenesis of chronic rhinosinusitis. In particular, we highlight the increasing recognition of host-mediated mechanisms in driving mucosal inflammation. RECENT
FINDINGS: Published differences between epithelium from patients with chronic rhinosinusitis and normal controls can be classified into several broad categories. Alterations are reported in the various components of the epithelial innate immune system including epithelial-expressed pattern-recognition receptors (PRRs) and the levels of antimicrobial innate immune effector molecules. Other studies demonstrate differences in the proteins involved in maintaining epithelial barrier integrity. Finally, recent studies show in chronic rhinosinusitis that epithelial-derived cytokines, chemokines and inducible surface proteins are involved in recruiting and activating cells of the adaptive immune system.
CONCLUSION: The sinonasal epithelium provides a mechanical and innate immune barrier to a diverse array of environmental agents. This barrier also plays a key role in regulating the acquired mucosal immune response in the nose. Recent studies suggest that defects in this barrier may foster development of chronic sinonasal inflammation in response to environmental agents, and pathogenic or commensal organisms. The ability to dissect and analyze defects in the inflammatory response in rhinosinusitis may help identify novel targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19966566      PMCID: PMC3092705          DOI: 10.1097/MOO.0b013e3283350053

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  70 in total

1.  The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.

Authors:  Fenna A Ebbens; Christos Georgalas; Silvia Luiten; Cornelis M van Drunen; Lydia Badia; Glenis K Scadding; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Valerie J Lund; W J Fokkens
Journal:  Laryngoscope       Date:  2009-02       Impact factor: 3.325

Review 2.  Molecular networks as sensors and drivers of common human diseases.

Authors:  Eric E Schadt
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

3.  Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway.

Authors:  Zhen Dong; Zhanquan Yang; Chengshuo Wang
Journal:  Am J Rhinol       Date:  2005 May-Jun

4.  Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils.

Authors:  Seung-Heon Shin; Young-Ho Lee; Chang-Ho Jeon
Journal:  Acta Otolaryngol       Date:  2006-12       Impact factor: 1.494

5.  The diagnosis and incidence of allergic fungal sinusitis.

Authors:  J U Ponikau; D A Sherris; E B Kern; H A Homburger; E Frigas; T A Gaffey; G D Roberts
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

Review 6.  IL-22: a critical mediator in mucosal host defense.

Authors:  S J Aujla; J K Kolls
Journal:  J Mol Med (Berl)       Date:  2009-02-14       Impact factor: 4.599

7.  Detection of enterotoxin DNA in Staphylococcus aureus strains obtained from the middle meatus in controls and nasal polyp patients.

Authors:  Thibaut Van Zele; Mario Vaneechoutte; Gabriele Holtappels; Philippe Gevaert; P van Cauwenberge; Claus Bachert
Journal:  Am J Rhinol       Date:  2008 May-Jun

8.  T-cell regulation in chronic paranasal sinus disease.

Authors:  Nicholas Van Bruaene; Claudina Angela Pérez-Novo; Tomasz M Basinski; Thibaut Van Zele; Gabriele Holtappels; Natalie De Ruyck; Carsten Schmidt-Weber; Cezmi Akdis; Paul Van Cauwenberge; Claus Bachert; Philippe Gevaert
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

Review 9.  The mold conundrum in chronic rhinosinusitis: where do we stand today?

Authors:  Fenna A Ebbens; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

10.  TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells.

Authors:  Atsushi Kato; Silvio Favoreto; Pedro C Avila; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

View more
  41 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

Review 2.  Is there a future for biologics in the management of chronic rhinosinusitis?

Authors:  Kent Lam; Robert C Kern; Amber Luong
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-22       Impact factor: 3.858

3.  Atopic profile of patients failing medical therapy for chronic rhinosinusitis.

Authors:  Bruce K Tan; Whitney Zirkle; Rakesh K Chandra; David Lin; David B Conley; Anju T Peters; Leslie C Grammer; Robert P Schleimer; Robert C Kern
Journal:  Int Forum Allergy Rhinol       Date:  2011 Mar-Apr       Impact factor: 3.858

Review 4.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

5.  Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis.

Authors:  Andor Hirschberg; Maria Kiss; Edit Kadocsa; Hilda Polyanka; Kornelia Szabo; Zsolt Razga; Zsolt Bella; Laszlo Tiszlavicz; Lajos Kemeny
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-30       Impact factor: 2.503

6.  Searching for distinct mechanisms in eosinophilic and noneosinophilic airway inflammation.

Authors:  Atsushi Kato; Kathryn E Hulse
Journal:  Am J Respir Crit Care Med       Date:  2014-09-15       Impact factor: 21.405

7.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

Review 8.  Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter.

Authors:  Kathleen Dass; Anju Tripathi Peters
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

9.  Activations of group 2 innate lymphoid cells depend on endotypes of chronic rhinosinusitis.

Authors:  Lin Lin; Jinjin Wei; Zheng Chen; Xinyue Tang; Fei Dai; Guangbin Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-24       Impact factor: 2.503

10.  Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression.

Authors:  Kathryn E Hulse; James E Norton; Lydia Suh; Qiu Zhong; Mahboobeh Mahdavinia; Patrick Simon; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Roderick G Carter; Atsushi Kato; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-06       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.